FULC
Fulcrum Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Fulcrum Therapeutics (FULC) Stock: Buy, Sell, or Hold?
$3.74
+0.02 (+0.54%)
▲
5d:
-0.8%
30d:
+1.63%
90d:
+0.81%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (74%)
Quality Score
60/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$3.67 – $3.74
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-6.8x
Next 12M consensus est.
Wall Street Target
$3.67
-2.0% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.64 / $3.80
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: FULC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Get Alerted When FULC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: FULC is currently trading at $3.74, which is considered slightly high relative to its 30-day fair value range of $3.67 to $3.74.
Technical Outlook: Technically, FULC is showing sideways momentum. The price is currently testing key support at $3.64. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: FULC scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FULC is showing sideways momentum. The price is currently testing key support at $3.64. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: FULC scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.67 -
$3.74
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.7%
Trading Range & Key Levels
30-Day Trading Range
$3.67 -
$3.74
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$3.64
Resistance Level
$3.80
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Strong technical setup (74/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($3.67)
- BULLISH: Bottoming setup score 74/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-6.83
Wall Street Target
$3.67
(-2.0%)
Revenue Growth (YoY)
-100.0%
Share FULC Analysis
Share this live FULC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (FULC)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 21, 2026
Daily AI digest
AI Retail Discussion Summary:
Significant bullish sentiment on StockTwits as 10% owner Keven Tang bought additional 249,946 shares of $FULC for approximately $891K.
Key Retail Themes:
Share buyback by significant investor
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:45 AM ET
Data refreshes hourly during market hours. Next update: 3:45 AM
Data refreshes hourly during market hours. Next update: 3:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FULC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 32 SELL |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
14 analysts |
$34 | 52 HOLD |
|
PALI
Palisade Bio Inc |
STRONG BUY
10 analysts |
$10 | 62 BUY |
Advanced FULC Option Strategies
Professional options setups generated by AI based on today's FULC price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive FULC Research Pages
